NCT06657430招募中不适用
A Study on the Preference of Risperidone Dosage Forms
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine
研究概览
简要总结
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
详细描述
This study aims to understand patients' needs and preferences for antipsychotic dosage forms and to clarify the clinical value of patch-form antipsychotics.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.
排除标准
- •Have difficulty reading and understanding Chinese or refuse to participate in the study.
结局指标
主要结局
Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine
时间窗: "through study completion, an average of 6 months
The proportion of patients (and their caregivers) who preferred risperidone patch among the respondents in this study
次要结局
- Factors related to patients' preference for risperidone patch-form medicines(through study completion, an average of 6 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaPsychotic DisorderSchizophreniaNCT00249119Janssen, LP1,579
终止
4 期
Optimizing Response in Psychosis StudySchizophreniform DisorderPsychotic Disorder Not Otherwise SpecifiedSchizophreniaSchizoaffective DisorderNCT00314327Northwell Health1
已完成
3 期
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With HaloperidolManic DisorderBipolar DisordersNCT00253162Johnson & Johnson Pharmaceutical Research & Development, L.L.C.439
已完成
3 期
A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaAlzheimer DiseaseDementia, VascularDementiaNCT00249145Janssen Pharmaceutica N.V., Belgium349
终止
4 期
A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationSchizophreniaNCT00256997Janssen-Ortho Inc., Canada167